SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-030147
Filing Date
2015-05-13
Accepted
2015-05-13 16:09:10
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 EXHIBIT 10-Q v409509_10q.htm 10-Q 243025
2 EXHIBIT 31.1 v409509_ex31-1.htm EX-31.1 9664
3 EXHIBIT 31.2 v409509_ex31-2.htm EX-31.2 9766
4 EXHIBIT 32 v409509_ex32.htm EX-32 3251
  Complete submission text file 0001144204-15-030147.txt   3491413

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT clcs-20150331.xml EX-101.INS 571171
6 XBRL TAXONOMY EXTENSION SCHEMA clcs-20150331.xsd EX-101.SCH 26372
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clcs-20150331_cal.xml EX-101.CAL 23957
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clcs-20150331_def.xml EX-101.DEF 141048
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE clcs-20150331_lab.xml EX-101.LAB 189279
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clcs-20150331_pre.xml EX-101.PRE 175431
Mailing Address 2620 REGATTA DR. STE 102 LAS VEGAS NV 89128
Business Address 2620 REGATTA DR. STE 102 LAS VEGAS NV 89128 18889709463
Cell Source, Inc. (Filer) CIK: 0001569340 (see all company filings)

IRS No.: 320379665 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55413 | Film No.: 15858480
SIC: 2834 Pharmaceutical Preparations